Velleca Mark A. has filed 4 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 600000 shares of Black Diamond Therapeutics, Inc. ($BDTX) on January 21, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 21, 2026 | Black Diamond Therapeutics, Inc. | $BDTX | Velleca Mark A. | PRESIDENT & CEO | A | Stock Option (Right to Buy) | 600000 | $0.00 | 600,000.0000 | 57,480,512 | 9999.99% | 1.04% |
| Jan. 30, 2025 | Black Diamond Therapeutics, Inc. | $BDTX | Velleca Mark A. | PRESIDENT & CEO | A | Common Stock | 75000 | $0.00 | 121,522.0000 | 55,028,371 | 161.21% | 0.14% |
| Jan. 30, 2025 | Black Diamond Therapeutics, Inc. | $BDTX | Velleca Mark A. | PRESIDENT & CEO | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 55,028,371 | 9999.99% | 0.91% |
| Feb. 14, 2024 | Black Diamond Therapeutics, Inc. | $BDTX | Velleca Mark A. | PRESIDENT & CEO | A | Stock Option (Right to Buy) | 537000 | $0.00 | 537,000.0000 | 43,954,649 | 9999.99% | 1.22% |